We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

21 hedge funds and large institutions have $6.4M invested in ImmuCell in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

43% more capital invested

Capital invested by funds: $4.49M → $6.4M (+$1.91M)

17% more funds holding

Funds holding: 18 → 21 (+3)

2% more ownership

Funds ownership: 12.02% → 14.02% (+2%)

Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ISL
Ingalls & Snyder LLC
New York
+$659K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$94.9K
3
Renaissance Technologies
Renaissance Technologies
New York
+$18K
4
SRC
Shufro Rose & Co
New York
+$14.4K
5
Bank of America
Bank of America
North Carolina
+$7.97K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$11K
2
Wells Fargo
Wells Fargo
California
-$7.2K
3
Deutsche Bank
Deutsche Bank
Germany
-$720
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
Heartland Advisors
Wisconsin
$1.66M – – –
PCM
2
Perritt Capital Management
Illinois
$1.28M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$801K +$18K +2,500 +3%
ISL
4
Ingalls & Snyder LLC
New York
$762K +$659K +91,511 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$595K +$2.18K +303 +0.4%
SRC
6
Shufro Rose & Co
New York
$423K +$14.4K +2,000 +4%
EFS
7
Essex Financial Services
Connecticut
$198K – – –
MA
8
Minerva Advisors
Pennsylvania
$121K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$110K +$94.9K +13,187 New
RC
10
RBF Capital
California
$109K – – –
Morgan Stanley
11
Morgan Stanley
New York
$98K +$3.6K +500 +4%
Northern Trust
12
Northern Trust
Illinois
$87K – – –
Deutsche Bank
13
Deutsche Bank
Germany
$37K -$720 -100 -2%
UBS Group
14
UBS Group
Switzerland
$35K -$11K -1,528 -26%
FHA
15
Flagship Harbor Advisors
Massachusetts
$26K – – –
Bank of America
16
Bank of America
North Carolina
$26K +$7.97K +1,108 +54%
BlackRock
17
BlackRock
New York
$12K – – –
Citigroup
18
Citigroup
New York
$8K +$6.69K +930 New
TRCT
19
Tower Research Capital (TRC)
New York
$2K +$914 +127 +76%
Wells Fargo
20
Wells Fargo
California
– -$7.2K -1,000 -100%

ICCC Hedge Fund Activity: Q3 2018 in Review

21 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2018, worth a combined $6.4M — up 43% from $4.49M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ICCC positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Ingalls & Snyder LLC, opening a new position worth an estimated $659K. The largest seller was UBS Group, cutting an estimated $11K.

  • 21 institutional investors held ImmuCell (ICCC) as of Q3 2018, up from 18 in Q2 2018.
  • Funds reported $6.4M of ImmuCell stock for Q3 2018, up 43% quarter-over-quarter.
  • 3 funds opened new ImmuCell positions in Q3 2018 and 0 closed out, a net change of +3 holders.
  • The largest ImmuCell buyer in Q3 2018 was Ingalls & Snyder LLC, an estimated $659K added.
  • The largest ImmuCell seller in Q3 2018 was UBS Group, an estimated $11K sold.

Based on aggregated 13F filings for Q3 2018.